DESIGN AND DEVELOPMENT OF ANTI-ULCER DRUG DERIVATIVES FOR ANALYTICAL STUDIES

ABSTRACT
Based on current research in medicinal chemistry, specifically regarding the design and
development of anti-ulcer derivatives, an abstract for this topic typically focuses on
synthesizing new molecules (such as benzimidazole or isoxazole hybrids) to improve efficacy
while reducing side effects like GI toxicity. Below is a structured abstract following standard
academic conventions for this field: Peptic ulcers remain a significant global health concern,
characterized by mucosal erosions in the gastrointestinal tract. While conventional therapies
like Proton Pump Inhibitors (PPIs) and H_2 receptor antagonists are effective, they are often
associated with side effects, drug interactions, and potential relapses. Furthermore, the chronic
use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) is a leading cause of gastric injury,
necessitating the development of "gastro-sparing" or hybrid anti-inflammatory agents.